![The new kid on the block – 'Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box' – HESW Respiratory The new kid on the block – 'Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box' – HESW Respiratory](https://openres.ersjournals.com/content/erjor/5/1/00185-2018/F1.large.jpg?width=800&height=600&carousel=1)
The new kid on the block – 'Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box' – HESW Respiratory
![Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12931-021-01777-x/MediaObjects/12931_2021_1777_Fig6_HTML.png)
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text
![LABA/LAMA vs ICS/LABA for exacerbations - Management of Stable COPD - GOLD COPD 2017 Resource Center: Activity Five LABA/LAMA vs ICS/LABA for exacerbations - Management of Stable COPD - GOLD COPD 2017 Resource Center: Activity Five](http://www.webedcafe.com/extern/program_media/goldcopd.org/2017/stable_COPD//figure_images/PNGw714/Slide26c.png)
LABA/LAMA vs ICS/LABA for exacerbations - Management of Stable COPD - GOLD COPD 2017 Resource Center: Activity Five
![Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/4-Figure1-1.png)
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369219300145-gr1.jpg)
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
![Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369219342254-gr1.jpg)
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect
![Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14237d6f07c90838ca1277212ca4bae185748743/3-Figure1-1.png)
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
![Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/7-Figure2-1.png)
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - ScienceDirect Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213260018303680-gr1.gif)
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - ScienceDirect
![ARM | Free Full-Text | ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts ARM | Free Full-Text | ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts](https://pub.mdpi-res.com/arm/arm-90-00051/article_deploy/html/images/arm-90-00051-g003.png?1664449977)
ARM | Free Full-Text | ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts
![JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations](https://pub.mdpi-res.com/jcm/jcm-11-06623/article_deploy/html/images/jcm-11-06623-g001.png?1668766997)
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
![Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram](https://www.researchgate.net/publication/326206557/figure/fig1/AS:645018255642634@1530795744549/Algorithm-for-withdrawal-of-ICS-in-symptomatic-patients-with-COPD-a-Note-a-If.png)
Algorithm for withdrawal of ICS in symptomatic patients with COPD. a... | Download Scientific Diagram
![Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14237d6f07c90838ca1277212ca4bae185748743/5-Table1-1.png)